Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Novi Iskar

8 clinical trials in Novi Iskar, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Novi Iskar at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Novi Iskar

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Novi Iskar

What the registry says about research in the country

01 Psychiatric Research

Innovative clinical trials focusing on schizophrenia treatment are currently underway, investigating new therapeutic approaches for patients with inadequately controlled symptoms.

  • Symptom Management Studies
  • Treatment Efficacy Assessment
  • Long-term Safety Evaluation

These studies evaluate novel adjunctive therapies using the Positive and Negative Syndrome Scale to measure treatment effectiveness, aiming to improve patient outcomes in psychiatric care.

02 Mental Health Therapeutics

Research initiatives are exploring combination therapy approaches for individuals whose schizophrenia symptoms are not adequately controlled by current treatments.

  • Novel Drug Combinations
  • Extended Duration Studies
  • Treatment Tolerability

The research encompasses both immediate efficacy assessment and extended monitoring to ensure sustainable therapeutic benefits.

03 Clinical Safety Studies

Comprehensive investigations of adjunctive treatments are being conducted to establish both immediate and long-term safety profiles for new therapeutic interventions.

  • Safety Monitoring
  • Treatment Continuation
  • Patient Response Analysis

These trials include rollover studies to gather extended safety data and evaluate ongoing treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.